Crown Laboratories and Revance Will Merge in $924 Million Deal
In a significant move within the medical aesthetics industry, Crown Laboratories has announced its plans to merge with Revance Therapeutics in a deal valued at $924 million. Crown Laboratories, recognized for its Blue Lizard sunscreen and Strivectin skincare line, aims to leverage Revance’s expertise in injectables, including popular hyaluronic acid fillers and its Botox alternative, […]